The Effectiveness of Dry Needling Treatment in Patients Diagnosed With Dorsal Myofascial Pain Syndrome.
NCT ID: NCT06338514
Last Updated: 2025-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2024-04-25
2025-11-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effectiveness of Dry Needling Treatment in Patients With Shoulder Myofascial Pain Syndrome
NCT06338488
Efficacy of Dry Needling Treatment in Myofascial Pain Syndrome
NCT05066529
Evaluation of the Efficacy and Neurological Effects of Dry Needling in the Treatment of Myofascial Pain Syndrome
NCT02179320
The Efficiency of Dry Needling and Cold Spray-stretching Treatments
NCT05664165
Treatment of Upper Trapezius Muscle Myofascial Pain Syndrome
NCT06546124
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In the dry needling application, thinner needles with a gauge of 27 and a length of 5 cm, which are significantly finer than conventional standard injection needles, will be used in both the study and sham groups. These needles minimize tissue irritation due to their finer tip, targeting the trigger points in the trapezius and rhomboid muscles on the standard painful side in the study group and the subcutaneous fatty tissue in the same regions in the sham group.
Throughout the study period, all patients in both groups will be instructed in detail on the daily exercises they need to perform (trapezius stretching and rhomboid stretching exercises), as well as on important considerations (avoiding prolonged static positions, etc.). They will be encouraged to perform these exercises daily and mark their completion. Additionally, they will be informed about the selection and usage of medications (only paracetamol) that they can use when necessary, along with instructions on adherence and marking on the provided follow-up form. The entire process will be monitored weekly through the follow-up form provided to the patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dry needling group (study group)
Real dry needling into the muscle under ultrasound guidance.
Real dry needling
dry needling into the muscle under ultrasound guidance.
Sham dry needling group (control group)
Sham dry needling into the subcutaneous fatty tissue under ultrasound guidance.
Sham dry needling
dry needling into the subcutaneous fatty tissue under ultrasound guidance.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Real dry needling
dry needling into the muscle under ultrasound guidance.
Sham dry needling
dry needling into the subcutaneous fatty tissue under ultrasound guidance.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having a shoulder pain Visual Analog Scale (VAS) score of 6 or higher.
* Ability to read and write
Exclusion Criteria
* Lesions, atrophy, or scars in the skin around the back.
* Undergoing physiotherapy targeting the back and lumbar region in the last 6 months.
* Undergoing an interventional procedure for back or lumbar pain in the last 3 months.
* Use of steroids in the last 1 month.
* Special conditions such as epilepsy, pregnancy, injection phobia, etc.
* Inability to comply with the restriction on the use of steroid and non-steroidal anti-inflammatory drugs during the treatment period.
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kutahya Health Sciences University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hasan Hüseyin Gökpınar
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hasan H Gökpınar, Ass. Prof.
Role: PRINCIPAL_INVESTIGATOR
Kutahya Health Sciences University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kütahya Health Sciences University
Kütahya, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KutahyaHSU-DRYNEEDLE-dorsalgia
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.